158 filings
Page 5 of 8
8-K
4ic5usxrljc
6 Feb 06
Entry into a Material Definitive Agreement
12:00am
8-K
tovi5xso9tuy nrk7x6
7 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
2ut4bky8 kzjdvdr
28 Oct 05
Kosan Reports Third Quarter and Nine-Month Financial Results
12:00am
CORRESP
0pqqnpx3 q6
25 Oct 05
Correspondence with SEC
12:00am
8-K
qe6gdg9
28 Sep 05
Other Events
12:00am
CORRESP
ca6d3tc6fy89
12 Sep 05
Correspondence with SEC
12:00am
8-K
i86izp9794v9hp
12 Sep 05
Other Events
12:00am
8-K
4afcma4q8v3jhk6
16 Aug 05
Kosan Announces Termination of Common Stock Offering
12:00am
8-K
o1k6opn
15 Aug 05
Update on Nci-sponsored 17-AAG and Dmag Clinical Trials
12:00am
424B3
2q8v 6r3iqq9
15 Aug 05
Prospectus supplement
12:00am
424B5
cdnbc3y dcs4j8mpmik
11 Aug 05
Prospectus supplement for primary offering
12:00am
8-K
udq72 wn7i0npej3zo1d
11 Aug 05
Kosan Announces Offering of 4,500,000 Shares of Common Stock
12:00am
424B3
ack6hacir5c
5 Aug 05
Prospectus supplement
12:00am
8-K
2jgwn1t5
2 Aug 05
Kosan Reports Second Quarter and Six-Month Financial Results
12:00am
8-K
g1fcny fo7fm1exc
18 Jul 05
Kosan Secures $35 Million Line of Credit
12:00am
8-K
easox65rkx nsae
30 Jun 05
Entry into a Material Definitive Agreement
12:00am
8-K
03bn85n0gylb
29 Apr 05
Kosan Reports First Quarter Financial Results
12:00am